MARCH 27
Days
- :
Hrs
- :
Min
- :
Sec
ePoster Gallery
P090: Factors Driving Attrition to Pancreatectomy in Patients Undergoing Neoadjuvant Therapy for Localized Pancreatic Cancer
Erin Dickey MD, MBS
University of Miami
P091: Flower monoclonal antibody works synergistically with standard of care chemotherapy to attenuate tumor growth and metastasis in pancreatic ductal adenocarcinoma
Vignesh Vudatha
VCU Health
P092: GATA6 immunohistochemistry is not predictive of tumor subtype in pancreatic ductal adenocarcinoma
Jaewon Lee
University of North Carolina at Chapel Hill
P093: Genomic Profiling Reveals Predictors of Response to Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma
Gregor Werba MD
UPMC Medical Center
P094: Glycan-Targeted Therapy with Triplatin for Effective Treatment of Pancreatic & Ovarian Cancer
Vashti Bandy
VIRGINIA COMMONWEALTH UNIVERSITY
P095: Identifying Risk Factors for Post-Hepatectomy Liver Failure in Patients with Adequate Liver Remnants: A Single-Center, Retrospective Analysis.
Sumaya Ghaffar MD
University of Colorado Denver | Anschutz Medical Campus
P096: Impact of neoadjuvant therapy on the outcomes of patients with adenosquameous carcinoma of the pancreas
Amanda Walsh BS
The Ohio State University
P097: Impact of Reclassification on Osteoclast-like Giant Cell Carcinoma of the Pancreas: A Comparative Analysis
Bianca Bechini
P098: Improving Quality through the Systematic Review of All Abnormal Pancreatic Imaging Findings
Leslie Shaw PA-C
University Hospitals of Cleveland
P099: Investigation of the tumor microenvironment of orthotopically implanted tumor organoids and its utility as a preclinical model of pancreatic cancer
Brian Griffith
University of Michigan
P100: Leveraging the functional specialization of neutrophillic myeloid derived suppresor cells as a predictive biomarker in pancreatic cancer
Manan Patel MBBS
University of Miami
P101: Lighting Up PNET: Creating a Murine Model with a Novel Bioluminescent Cell Line
Rachel Nation MD, MPH
Cooper University Hospital
P102: Loss of Smad4 in Genetically Engineered Mouse Models of Pancreatic Cancer Impairs Survival and Alters the Tumor Microenvironment
Gilbert Murimwa M.D
UTSouthwestern Medical Center
P103: Minimally Invasive Hepatectomy for Colorectal Liver Metastasis: Comparative Study of Laparoscopic vs Robotic Approach In A Large Multicenter Cohort of Patients
Samy Castillo-Flores
University of Texas Southwestern
P104: Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma: Reassessing Survival and Recurrence After Adjusting for Immortal Time Bias
Amir Ashraf Ganjouei
University of California San Francisco
P105: Octogenarians Undergoing Pancreaticoduodenectomy versus Definitive Radiotherapy for Locoregional Therapy of Pancreatic Ductal Adenocarcinoma
Muhammad Muntazir Mehdi Khan MBBS
Allegheny Health Network
P106: Optimizing Clinical Trial Design May Mitigate Racial Disparities in Pancreatic Cancer Clinical Trial Enrollment
Tracey Pu MD
Department of Surgery, University of Alabama
P107: Pancreaticoduodenectomy with Intraoperative Radiation Therapy for Borderline and Locally Advanced Pancreatic Cancer: A Propensity Score Matched Survival Analysis
Katherine Poruk
Mayo Clinic - Florida